RadMD

RadMD is the global leader in providing medical imaging expertise for clinical trials. Founded by Drs. Richard Patt and Kohkan Shamsi, both radiologists, who each bring over 20 years of pharmaceutical clinical development, regulatory, and imaging experience. RadMDs expertise is focused on developing clinico-regulatory compliant strategies to implement imaging efficacy and safety endpoints in trials from Phase 1 (e.g. improving go/no-go decision making) through Phase 4 (e.g. imaging-enabled registries). We are the only company that offers category 1 ACCME-certified web based training and testing on imaging efficacy criteria (i.e., RECIST, Cheson, PAMRIS, etc.), conducted through the Blinded Reader and Investigator...

Imaging in clinical trial,blinded reads,oncology trials,imaging diagnostics,contrast agents,alzheimers trials,image analysis,bicr,and site reader training

Radmd operates in the Pharmaceutical manufacturing industry.

Radmd's revenue is 11m - 100m

Radmd has 11 - 50 employees.